Adaptimmune Announces Closing Of $42 Million Registered Direct Offering Post author:Sam Post published:April 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like No Doubt: This is the Top Gene-Sequencing Stock to Buy This Year April 20, 2017 Dova Pharma Announces Pricing Of Initial Public Offering June 28, 2017 New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson September 20, 2017
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson September 20, 2017